<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to&nbsp;Section 13 or&nbsp;15(d) of&nbsp;the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of&nbsp;1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Date of&nbsp;Report (Date of&nbsp;earliest event reported): December&nbsp;27,&nbsp;2018 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CNL HEALTHCARE PROPERTIES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of&nbsp;Registrant as&nbsp;Specified in&nbsp;its Charter) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Maryland</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">000-54685</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">27-2876363</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or&nbsp;Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of&nbsp;Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>450 South Orange Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orlando, Florida&nbsp;32801 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of&nbsp;Principal Executive Offices; Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area&nbsp;code: <FONT STYLE="white-space:nowrap">(407)&nbsp;650-1000</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the&nbsp;appropriate box below if&nbsp;the&nbsp;Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is&nbsp;intended to&nbsp;simultaneously satisfy
the&nbsp;filing obligation of&nbsp;the&nbsp;registrant under any of&nbsp;the&nbsp;following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to&nbsp;Rule 425 under the&nbsp;Securities Act (17 CFR 230.425)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to&nbsp;Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under
the&nbsp;Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to&nbsp;Rule <FONT
STYLE="white-space:nowrap">14d-2(b)&nbsp;under</FONT> the&nbsp;Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to&nbsp;Rule <FONT
STYLE="white-space:nowrap">13e-4</FONT> (c)&nbsp;under the&nbsp;Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;1.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entry into a Material Definitive Agreement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale of MOB Properties </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
December&nbsp;27, 2018, CHP Partners, LP, the operating partnership of CNL Healthcare Properties, Inc. (the &#147;Company&#148;), and certain subsidiaries of the Company (collectively, the &#147;Sellers&#148;), entered into an Agreement of Purchase
and Sale (the &#147;Sale Agreement&#148;) with Welltower OM Group LLC, a Delaware limited liability company owned by Welltower Inc., an Ohio corporation (the &#147;Purchaser&#148;), for the sale of 55 of the Company&#146;s medical office and related
properties (the &#147;Sale&#148;) for approximately $1.250&nbsp;billion in cash, subject to certain <FONT STYLE="white-space:nowrap">pro-rations</FONT> and other adjustments as described in the Sale Agreement (the &#147;Purchase Price&#148;). The
Company&#146;s board of directors (the &#147;Board&#148;) has unanimously approved the Company entering into the Sale Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
previously disclosed, in September 2018, the Company committed to a plan to sell its medical office buildings, post-acute care facilities and acute care hospitals across the US (&#147;MOB/Healthcare Portfolio&#148;), and the Sale is the first
transaction pursuant to this strategic shift. The real estate properties to be sold include 55 medical office building and related properties located in the United States, 54 in which the Company owns, directly or indirectly, 100% of the outstanding
equity interests in those properties and one property in which the Company owns, directly or indirectly, 90% of the outstanding equity interests in such property, along with, in each case, associated assets and future liabilities (other than
existing indebtedness) (the &#147;Properties&#148;). The actual Properties to be purchased by the Purchaser could be impacted by rights of first refusal or offer, which entitle various ground lessors or tenants to acquire those Properties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Sale Agreement, the Purchaser deposited $26&nbsp;million in cash into escrow as an earnest money deposit (the
&#147;Initial Deposit&#148;). The Sale Agreement provides that the Purchaser shall have until January&nbsp;17, 2019 to undertake an inspection of the Properties (the &#147;Inspection Period&#148;). In the event that the Purchaser determines no later
than the end of the Inspection Period that it does not wish to proceed with the purchase of the Properties, it may notify the Sellers, and upon such notification the parties shall no longer have any obligations under the Sale Agreement and the
Purchaser shall be entitled to a return of $25 million of the Initial Deposit. In the event that the Purchaser wishes to proceed with the purchase of the Properties at the end of the Inspection Period, then the Purchaser shall deposit an additional
$50&nbsp;million in cash or provide a letter of credit in the same amount (together with the Initial Deposit, the &#147;Earnest Money&#148;), to be held in escrow until the consummation of the transactions contemplated by the Sale Agreement or until
the termination thereof and to be applied against the Purchase Price or delivered to the parties, respectively, upon termination as provided in the Sale Agreement. In the event that the Sale Agreement is terminated due to a breach by the Purchaser,
the Sellers shall be entitled to retain the Earnest Money. In the event that the Sale Agreement is terminated due to a breach by the Sellers, the Purchaser shall be entitled to a return of the Earnest Money. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sale Agreement contains customary representations and warranties of the Company and the Purchaser, as well as customary covenants of the
Company and the Purchaser. Additionally, the closing of the Sale is subject to the satisfaction or waiver of customary closing conditions set forth in the Sale Agreement. The parties anticipate that the closing of the Sale will occur in the first
half of 2019, although there can be no assurance that the closing conditions will be satisfied or that the Sale will be consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
foregoing description of the Sale Agreement does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the full text of the Sale Agreement that will be filed
with the Securities and Exchange Commission (&#147;SEC&#148;) as an exhibit to the Company&#146;s next periodic report. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming the
consummation of the sale of the Properties, the Company&#146;s remaining real estate portfolio will consist of 87 properties including 72 senior housing (the &#147;Senior Housing Portfolio&#148;) and fifteen acute care and post-acute care
properties. The Company expects to continue its efforts to sell the remaining five post-acute care facilities and three acute care hospitals as well as the six leased post-acute care facilities previously identified as held for sale, although there
can be no guarantee that any or all of these properties will be sold at any particular time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company currently estimates it will use approximately $430 million in Sales proceeds to
pay costs related to closing and repay indebtedness currently secured by the Properties being sold to Purchaser pursuant to the Sale Agreement. Subject to approval of the Board, the Company anticipates using the remainder of the proceeds to
rebalance corporate borrowings, make a special distribution to stockholders and for other liquidity needs of the Company. Following the consummation of the Sale of the Properties, the Company will continue to own the Senior Housing Portfolio and
look for opportunities to enhance value in its remaining assets. The Company will continue to monitor its ongoing cash distributions in connection with its operations and ownership of the Senior Housing Portfolio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">HFF Securities L.P. and KeyBanc Capital Markets Inc. served as financial advisors to the Special Committee of the Company in connection with
the Sale. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulation FD Disclosure </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has posted to its website (http://www.cnlhealthcareproperties.com) and will mail to its stockholders a letter notifying them of the
transactions contemplated by the Sale Agreement and advising stockholders of related matters. A copy of the stockholder letter is filed as Exhibit 99.1 to this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and is incorporated
herein by reference solely for the purposes of this Item 7.01 disclosure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the rules and regulations of the SEC, the
information contained in this Item 7.01 disclosure, including Exhibit 99.1 and the information set forth therein, is deemed to have been furnished and shall not be deemed to be &#147;filed&#148; under the Securities Exchange Act of 1934, as amended
(the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of such section, nor shall any of such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By furnishing the information contained in this Item 7.01
disclosure, including Exhibit 99.1, the Company makes no admission as to the materiality of such information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Caution Concerning Forward-Looking
Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information above contains &#147;forward-looking statements&#148; within the meaning of the Federal Private Securities
Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbor created by Section&nbsp;21E of the Exchange Act. Forward-looking statements are statements that do not relate strictly to
historical or current facts, but reflect management&#146;s current understandings, intentions, beliefs, plans, expectations, assumptions and/or predictions regarding the future of the Company&#146;s business and its performance, the economy, and
other future conditions and forecasts of future events, and circumstances. Forward-looking statements are typically identified by words such as &#147;believes,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;intends,&#148;
&#147;estimates,&#148; &#147;plans,&#148; &#147;continues,&#148; &#147;pro forma,&#148; &#147;may,&#148; &#147;will,&#148; &#147;seeks,&#148; &#147;should&#148; and &#147;could,&#148; and words and terms of similar substance. Although the Company
believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual results could differ materially from those set forth in the forward-looking statements due to a variety of risks, uncertainties
and other factors. Such factors include, but are not limited to, the satisfaction or waiver of other conditions in the Sale Agreement; the risk that the Sale or the other transactions contemplated by the Sale Agreement may not be completed in the
time frame expected by the parties or at all; the ability of the Company to implement its operating strategy; changes in economic cycles; the impact of changes in accounting rules; the impact of regulations requiring periodic valuation of the
Company on a per share basis; inaccuracies of the Company&#146;s accounting estimates; failure to maintain the Company&#146;s REIT qualification; and the Company&#146;s inability to protect its intellectual property and the value of its brand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further information regarding risks and uncertainties associated with the Company&#146;s business, and important factors that could cause the
Company&#146;s actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described under &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations&#148; and the &#147;Risk Factors&#148; sections of the Company&#146;s documents filed from time to time with the SEC, including, but not limited to, the Company&#146;s quarterly reports
<FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q,&nbsp;and</FONT> the Company&#146;s annual report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-K,&nbsp;copies</FONT> of which may be obtained from the Company&#146;s website at
http://www.cnlhealthcareproperties.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All written and oral forward-looking statements attributable to the Company or persons acting on its behalf
are qualified in their entirety by these cautionary statements. Forward-looking statements speak only as of the date on which they are made; the Company undertakes no obligation to, and expressly disclaims any obligation to, update or revise its
forward-looking statements to reflect new information, changed assumptions, the occurrence of subsequent events, or changes to future operating results over time unless otherwise required by law. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) Exhibits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.1&nbsp;&nbsp;&nbsp;&nbsp;Letter to
Stockholders dated January&nbsp;2, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; "><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d679631dex991.htm">Letter to Stockholders dated January&nbsp;2, 2019. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the&nbsp;requirements of&nbsp;the&nbsp;Securities Exchange Act of&nbsp;1934, the&nbsp;registrant has&nbsp;duly caused
this&nbsp;report to&nbsp;be signed on&nbsp;its behalf by the&nbsp;undersigned hereunto&nbsp;duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated: January&nbsp;2,&nbsp;2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CNL HEALTHCARE PROPERTIES, INC.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">a&nbsp;Maryland corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Stephen H. Mauldin</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen H. Mauldin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
[{"type": "8-K", "sequence": "1", "filename": "d679631d8k.htm", "description": "8-K", "secsgml_size_bytes": 29707}]
{"company-data": {"conformed-name": "CNL Healthcare Properties, Inc.", "cik": "0001496454", "assigned-sic": "6798", "irs-number": "272876363", "state-of-incorporation": "MD", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54685", "film-number": "19502060"}, "business-address": {"street1": "450 SOUTH ORANGE AVENUE", "city": "ORLANDO", "state": "FL", "zip": "32801", "phone": "(407) 650-1000"}, "mail-address": {"street1": "450 SOUTH ORANGE AVENUE", "city": "ORLANDO", "state": "FL", "zip": "32801"}, "former-company": [{"former-conformed-name": "CNL Healthcare Trust, Inc.", "date-changed": "20120209"}, {"former-conformed-name": "CNL Properties Trust, Inc.", "date-changed": "20110301"}, {"former-conformed-name": "CNL Diversified Lifestyle Properties, Inc.", "date-changed": "20100713"}]}
8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 27, 2018
CNL HEALTHCARE PROPERTIES, INC.
(Exact Name of Registrant as Specified in its Charter)
Maryland
000-54685
27-2876363
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
450 South Orange Avenue
Orlando, Florida 32801
(Address of Principal Executive Offices; Zip Code)
Registrant's telephone number, including area code:
(407) 650-1000
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule
14a-12
under
the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule
14d-2(b) under
the Exchange Act (17 CFR
240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule
13e-4
(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 1.01
Entry into a Material Definitive Agreement
Sale of MOB Properties
On
December 27, 2018, CHP Partners, LP, the operating partnership of CNL Healthcare Properties, Inc. (the "Company"), and certain subsidiaries of the Company (collectively, the "Sellers"), entered into an Agreement of Purchase
and Sale (the "Sale Agreement") with Welltower OM Group LLC, a Delaware limited liability company owned by Welltower Inc., an Ohio corporation (the "Purchaser"), for the sale of 55 of the Company's medical office and related
properties (the "Sale") for approximately $1.250 billion in cash, subject to certain
pro-rations
and other adjustments as described in the Sale Agreement (the "Purchase Price"). The
Company's board of directors (the "Board") has unanimously approved the Company entering into the Sale Agreement.
As
previously disclosed, in September 2018, the Company committed to a plan to sell its medical office buildings, post-acute care facilities and acute care hospitals across the US ("MOB/Healthcare Portfolio"), and the Sale is the first
transaction pursuant to this strategic shift. The real estate properties to be sold include 55 medical office building and related properties located in the United States, 54 in which the Company owns, directly or indirectly, 100% of the outstanding
equity interests in those properties and one property in which the Company owns, directly or indirectly, 90% of the outstanding equity interests in such property, along with, in each case, associated assets and future liabilities (other than
existing indebtedness) (the "Properties"). The actual Properties to be purchased by the Purchaser could be impacted by rights of first refusal or offer, which entitle various ground lessors or tenants to acquire those Properties.
In connection with the Sale Agreement, the Purchaser deposited $26 million in cash into escrow as an earnest money deposit (the
"Initial Deposit"). The Sale Agreement provides that the Purchaser shall have until January 17, 2019 to undertake an inspection of the Properties (the "Inspection Period"). In the event that the Purchaser determines no later
than the end of the Inspection Period that it does not wish to proceed with the purchase of the Properties, it may notify the Sellers, and upon such notification the parties shall no longer have any obligations under the Sale Agreement and the
Purchaser shall be entitled to a return of $25 million of the Initial Deposit. In the event that the Purchaser wishes to proceed with the purchase of the Properties at the end of the Inspection Period, then the Purchaser shall deposit an additional
$50 million in cash or provide a letter of credit in the same amount (together with the Initial Deposit, the "Earnest Money"), to be held in escrow until the consummation of the transactions contemplated by the Sale Agreement or until
the termination thereof and to be applied against the Purchase Price or delivered to the parties, respectively, upon termination as provided in the Sale Agreement. In the event that the Sale Agreement is terminated due to a breach by the Purchaser,
the Sellers shall be entitled to retain the Earnest Money. In the event that the Sale Agreement is terminated due to a breach by the Sellers, the Purchaser shall be entitled to a return of the Earnest Money.
The Sale Agreement contains customary representations and warranties of the Company and the Purchaser, as well as customary covenants of the
Company and the Purchaser. Additionally, the closing of the Sale is subject to the satisfaction or waiver of customary closing conditions set forth in the Sale Agreement. The parties anticipate that the closing of the Sale will occur in the first
half of 2019, although there can be no assurance that the closing conditions will be satisfied or that the Sale will be consummated.
The
foregoing description of the Sale Agreement does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the full text of the Sale Agreement that will be filed
with the Securities and Exchange Commission ("SEC") as an exhibit to the Company's next periodic report.
Assuming the
consummation of the sale of the Properties, the Company's remaining real estate portfolio will consist of 87 properties including 72 senior housing (the "Senior Housing Portfolio") and fifteen acute care and post-acute care
properties. The Company expects to continue its efforts to sell the remaining five post-acute care facilities and three acute care hospitals as well as the six leased post-acute care facilities previously identified as held for sale, although there
can be no guarantee that any or all of these properties will be sold at any particular time.
2
The Company currently estimates it will use approximately $430 million in Sales proceeds to
pay costs related to closing and repay indebtedness currently secured by the Properties being sold to Purchaser pursuant to the Sale Agreement. Subject to approval of the Board, the Company anticipates using the remainder of the proceeds to
rebalance corporate borrowings, make a special distribution to stockholders and for other liquidity needs of the Company. Following the consummation of the Sale of the Properties, the Company will continue to own the Senior Housing Portfolio and
look for opportunities to enhance value in its remaining assets. The Company will continue to monitor its ongoing cash distributions in connection with its operations and ownership of the Senior Housing Portfolio.
HFF Securities L.P. and KeyBanc Capital Markets Inc. served as financial advisors to the Special Committee of the Company in connection with
the Sale.
Item 7.01
Regulation FD Disclosure
The Company has posted to its website (http://www.cnlhealthcareproperties.com) and will mail to its stockholders a letter notifying them of the
transactions contemplated by the Sale Agreement and advising stockholders of related matters. A copy of the stockholder letter is filed as Exhibit 99.1 to this Current Report on Form
8-K
and is incorporated
herein by reference solely for the purposes of this Item 7.01 disclosure.
Pursuant to the rules and regulations of the SEC, the
information contained in this Item 7.01 disclosure, including Exhibit 99.1 and the information set forth therein, is deemed to have been furnished and shall not be deemed to be "filed" under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall any of such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference in such a filing.
By furnishing the information contained in this Item 7.01
disclosure, including Exhibit 99.1, the Company makes no admission as to the materiality of such information.
Caution Concerning Forward-Looking
Statements
The information above contains "forward-looking statements" within the meaning of the Federal Private Securities
Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbor created by Section 21E of the Exchange Act. Forward-looking statements are statements that do not relate strictly to
historical or current facts, but reflect management's current understandings, intentions, beliefs, plans, expectations, assumptions and/or predictions regarding the future of the Company's business and its performance, the economy, and
other future conditions and forecasts of future events, and circumstances. Forward-looking statements are typically identified by words such as "believes," "expects," "anticipates," "intends,"
"estimates," "plans," "continues," "pro forma," "may," "will," "seeks," "should" and "could," and words and terms of similar substance. Although the Company
believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual results could differ materially from those set forth in the forward-looking statements due to a variety of risks, uncertainties
and other factors. Such factors include, but are not limited to, the satisfaction or waiver of other conditions in the Sale Agreement; the risk that the Sale or the other transactions contemplated by the Sale Agreement may not be completed in the
time frame expected by the parties or at all; the ability of the Company to implement its operating strategy; changes in economic cycles; the impact of changes in accounting rules; the impact of regulations requiring periodic valuation of the
Company on a per share basis; inaccuracies of the Company's accounting estimates; failure to maintain the Company's REIT qualification; and the Company's inability to protect its intellectual property and the value of its brand.
For further information regarding risks and uncertainties associated with the Company's business, and important factors that could cause the
Company's actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described under "Management's Discussion and Analysis of Financial Condition and
Results of Operations" and the "Risk Factors" sections of the Company's documents filed from time to time with the SEC, including, but not limited to, the Company's quarterly reports
on Form 10-Q, and
the Company's annual report
on Form 10-K, copies
of which may be obtained from the Company's website at
http://www.cnlhealthcareproperties.com.
3
All written and oral forward-looking statements attributable to the Company or persons acting on its behalf
are qualified in their entirety by these cautionary statements. Forward-looking statements speak only as of the date on which they are made; the Company undertakes no obligation to, and expressly disclaims any obligation to, update or revise its
forward-looking statements to reflect new information, changed assumptions, the occurrence of subsequent events, or changes to future operating results over time unless otherwise required by law.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
99.1    Letter to
Stockholders dated January 2, 2019.
4
EXHIBIT INDEX
Exhibit No.
Description
99.1
Letter to Stockholders dated January 2, 2019.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 2, 2019
CNL HEALTHCARE PROPERTIES, INC.
a Maryland corporation
By:
/s/ Stephen H. Mauldin
Stephen H. Mauldin
President and Chief Executive Officer